Cargando…
VEGFA Isoforms as Pro-Angiogenic Therapeutics for Cerebrovascular Diseases
Therapeutic angiogenesis has long been considered a viable treatment for vasculature disruptions, including cerebral vasculature diseases. One widely-discussed treatment method to increase angiogenesis is vascular endothelial growth factor (VEGF) A. In animal models, treatment with VEGFA proved bene...
Autores principales: | White, Amanda Louise, Bix, Gregory Jaye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136305/ https://www.ncbi.nlm.nih.gov/pubmed/37189449 http://dx.doi.org/10.3390/biom13040702 |
Ejemplares similares
-
Pro-angiogenic therapeutics for preeclampsia
por: Eddy, Adrian C., et al.
Publicado: (2018) -
The Potential Role of Integrin Signaling in Memory and Cognitive Impairment
por: Biose, Ifechukwude Joachim, et al.
Publicado: (2023) -
The balance of proangiogenic and antiangiogenic VEGFA isoforms regulate follicle development
por: McFee, Renee M., et al.
Publicado: (2012) -
Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinoma
por: Chesnokov, Mikhail S., et al.
Publicado: (2018) -
Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms: A NOVEL THERAPEUTIC STRATEGY FOR ANGIOGENESIS
por: Nowak, Dawid G., et al.
Publicado: (2010)